SCHEMBL484520

SCHEMBL484520

O=C(NC1CCc2ccc(C(=O)N3CCC4(CCN(Cc5ccc(F)cc5F)CC4)C3)cc21)c1cc(C(F)(F)F)ccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 7/20 0.40
CRHR2 Q13324 1/20 0.40
FAAH O00519 1/20 0.39
CYP3A4 P08684 4/20 0.39
MGLL Q99685 1/20 0.37
MRGPRX4 Q96LA9 1/20 0.37
TSHR P16473 4/20 0.37
CYP2D6 P10635 2/20 0.37
USP2 O75604 4/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
SCN1A P35498 1/20 0.35
SCN4A P35499 1/20 0.35
SCN7A Q01118 1/20 0.35
SCN5A Q14524 1/20 0.35
SCN9A Q15858 1/20 0.35
SCN2A Q99250 1/20 0.35
SCN3A Q9NY46 1/20 0.35
SCN8A Q9UQD0 1/20 0.35
KMT2A Q03164 1/20 0.35
ALDH1A1 P00352 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2816529 0.96 CYP3A4 (0.43) CRHR1CRHR2FAAHCYP3A4TSHR
SCHEMBL484764 0.95 CRHR1 (0.40) CRHR1CRHR2FAAHCYP3A4MGLL
SCHEMBL2816409 0.91 CYP3A4 (0.43) CRHR1CRHR2FAAHCYP3A4TSHR
SCHEMBL2816296 0.91 CYP3A4 (0.43) CRHR1CRHR2CYP3A4TSHRCYP2D6
SCHEMBL484790 0.90 CYP2D6 (0.40) CYP3A4TSHRCYP2D6USP2ALDH1A1
SCHEMBL484919 0.89 CYP3A4 (0.40) CRHR1CRHR2CYP3A4MRGPRX4TSHR
SCHEMBL484593 0.89 MRGPRX4 (0.40) CYP3A4MRGPRX4TSHRCYP2D6USP2
SCHEMBL2816489 0.88 CYP2D6 (0.37) CYP3A4TSHRCYP2D6KMT2AALDH1A1
SCHEMBL2817175 0.86 CRHR1 (0.42) CRHR1CRHR2CYP3A4MRGPRX4TSHR
SCHEMBL484813 0.86 USP2 (0.39) CRHR1FAAHCYP3A4MRGPRX4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN CRHR1 166/4885CRHR2 529/4885FAAH 1454/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN CRHR1 166/4885CRHR2 529/4885FAAH 1454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.